Andy T.

Andy T. has a diverse work experience spanning over 20 years. Andy is currently the Chief Commercial Officer (CCO) at The Patient Company, a role they started in 2023. Prior to this, they worked at BD Peripheral Intervention from 2019 to 2023, where they held the position of U.S. Commercialization & Sales Manager - endoAVF.

Before their time at BD, Andy worked at BD from 2017 to 2019, holding the roles of Sr. Manager of Sales Development and Regional Sales Manager on an interim basis.

From 2008 to 2017, Andy worked at CR Bard, where they held various positions, including Senior Manager of Market Development - BPV China, Manager of Sales Training and Development - Bard Peripheral Vascular, Field Manager - Bard Peripheral Vascular, and Territory Manager - Bard Access Systems.

Prior to CR Bard, Andy worked at Stryker Endoscopy as a Sales Rep from 2007 to 2008. Andy began their career at sanofi-aventis as a Sales Rep from 2005 to 2007, and prior to that, they worked as a Researcher at the National Institutes of Health from 2001 to 2003.

Andy T. completed a Bachelor of Science, Bachelor of Arts, and minor in Biochemistry/Chemistry and Zoology at North Carolina State University from 1998 to 2002. Their field of study during this time focused on biochemistry, chemistry, and zoology. Later, from 2018 to 2020, Andy pursued a Master of Business Administration (MBA) degree at UNC Kenan-Flagler Business School, specializing in Strategy, Finance, and Consulting.